Repligen Corp. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
68,169.60
63,548.30
83,537.00
104,541.00
141,236.00
194,032
Cost of Goods Sold (COGS) incl. D&A
26,185.20
28,022.00
36,851.00
47,117.00
73,265.00
97,109
Gross Income
41,984.40
35,526.30
46,686.00
57,424.00
67,971.00
96,923
SG&A Expense
19,020.00
21,945.40
28,839.00
35,994.00
53,535.00
68,035
EBIT
22,964.40
13,580.90
17,847.00
21,430.00
14,436.00
28,888
Unusual Expense
91.20
2,889.80
4,083.00
5,456.00
431.00
2,900
Non Operating Income/Expense
160.50
138.00
477.00
860.00
687.00
262
Interest Expense
-
-
-
3,768.00
6,441.00
6,709
Pretax Income
23,013.80
11,138.60
13,423.00
11,692.00
7,248.00
21,436
Income Tax
6,920.70
2,968.40
4,078.00
11.00
21,105.00
4,819
Consolidated Net Income
16,093.20
8,170.20
9,345.00
11,681.00
28,353.00
16,617
Net Income
16,093.20
8,170.20
9,345.00
11,681.00
28,353.00
16,617
Net Income After Extraordinaries
16,093.20
8,170.20
9,345.00
11,681.00
28,353.00
16,617
Net Income Available to Common
16,093.20
8,170.20
9,345.00
11,681.00
28,353.00
16,617
EPS (Basic)
0.50
0.25
0.28
0.34
0.72
0.37
Basic Shares Outstanding
31,667.00
32,497.70
32,881.90
33,572.90
38,233.50
43,767
EPS (Diluted)
0.50
0.25
0.28
0.34
0.72
0.37
Diluted Shares Outstanding
32,406.60
33,263.70
33,577.10
34,098.90
39,150.40
45,471
EBITDA
26,078.30
17,600.30
22,441.00
26,764.00
24,888.00
44,666
Non-Operating Interest Income
301.10
309.50
136.00
346.00
371.00
1,895

About Repligen

View Profile
Address
41 Seyon Street
Waltham Massachusetts 02453
United States
Employees -
Website http://www.repligen.com
Updated 07/08/2019
Repligen Corp. engages in the provision of bioprocessing technology and solutions. It operates through the following geographical segments: United States; Sweden; United Kingdom; and Other. It also serve through the following product lines: Protein; Filtration; Chromatography; and Other.